RenoP Cancer Research Results
RenoP, K,Renoprotection: Click to Expand ⟱
| Source: |
| Type: |
Protects kidneys
-Same as nephroprotective
Opposite is : Nephrotoxicity is toxicity in the kidneys
|
Scientific Papers found: Click to Expand⟱
*BioAv↓, absolute oral bioavailability of cucurbitacin B was approximately 10%.
*Half-Life↝, maximum concentration in plasma after normalization by dose ranged from 4.85–7.81 μg/L and the time to reach maximum value was approximately within 30 min after oral dosing.
*AST∅, The results demonstrated that after treatment, neither AST nor ALT changed significantly compared to prior treatment.
*ALAT∅,
*RenoP↝, Kidney function was determined by using creatinine as a biomarker and the results demonstrated that there was no difference between pre- and post-dosing.
*Half-Life↝, The elimination half-life was calculated from intravenous data and the value was approximately 5.08 ± 2.87 h.
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Total Targets: 0
Pathway results for Effect on Normal Cells:
Core Metabolism/Glycolysis ⓘ
ALAT∅, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, Half-Life↝, 2,
Clinical Biomarkers ⓘ
ALAT∅, 1, AST∅, 1,
Functional Outcomes ⓘ
RenoP↝, 1,
Total Targets: 6
Scientific Paper Hit Count for: RenoP, K,Renoprotection
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1175 State#:% Dir#:4
wNotes=on sortOrder:rid,rpid
Home Page